European Journal of Human Genetics - Clinical utility gene card for: 15q13.3 microdeletion syndrome
Clinical Utility Gene Card
European Journal of Human Genetics advance online publication 14 May 2014; doi: 10.1038/ejhg.2014.88
Clinical utility gene card for: 15q13.3 microdeletion syndrome
- 1MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, UK
- 2Institut de Génétique Médicale, CHRU de Lille, Lille, France
- 3Discovery Neuroscience Research, Eli Lilly and Company Ltd, Lilly Research Laboratories, Erl Wood Manor, Surrey, UK
Correspondence: Dr M Tropeano or Professor DA Collier, MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK. Tel: +44 20 7848 0631; Fax: +44 20 7848 0802; E-mail:maria.tropeano@kcl.ac.uk or david.collier@kcl.ac.uk
Received 27 January 2014; Revised 4 April 2014; Accepted 9 April 2014
Advance online publication 14 May 2014
Advance online publication 14 May 2014
Top
1. Disease characteristics
1.1 Name of the disease (synonyms)
15q13.3 microdeletion syndrome/Del(15)(q13.3)/15q13.3 monosomy syndrome.
1.2 OMIM# of the disease
612001.
1.3 Name of the analysed genes or DNA/chromosome segments
15q13.2q13.3, RefSeq NC_000015.9 (hg19 human reference sequence, February 2009, build 37).
1.4 OMIM# of the gene(s)
Putative candidate genes: CHRNA7, 118511; KLF13, 605328; TRPM1, 603576;FAN1, 613534.
Other genes in the critical deleted region (BP4-BP5): MTMR10, not applicable;MIR211, 613753; OTUD7A, 612024.
No hay comentarios:
Publicar un comentario